Good afternoon Honourable House.
This is an *alert*/ *Information* just reaching us from NAFDAC. The National Agency for Food and Drugs Administration and Control (NAFDAC) has been informed of the circulation of suspected counterfeit Augmentin 625mg Tabs in the country.
The information revealed that the supply came from Onitsha, Anambra State, and was
distributed at retail level.
Product Details;
Product Name: Augmentin 625mg.
Batch No.: 562626
Manufacturing date: April 2021
Expiry date: April 2024.
Nafdac Reg No: 04-1928.
Labelling Lapses:
The product failed short of the following labeling requirements.
•No inscription of manufactured by written on the label, only the address.
•Manufacturing and Expiry dates don't meet the acceptable format.
•No MAS scratch number for verification.
•The logo "gsk" is not properly positioned as on the original.
The above information makes the drug suspected as counterfeit.
You are hereby requested to inform your members to be vigilant and report any Substandard Augmentine 625mg in their inventory to the nearest NAFDAC office or call 08001623322 /send email to sf.alert@nafdac.gov.ng.
Thank you.
Comments
Post a Comment
What can you say.